Technical Analysis for BHC - Bausch Health Companies Inc.

Grade Last Price % Change Price Change
grade B 29.55 -1.17% -0.350
BHC closed down 1.17 percent on Tuesday, October 22, 2019, on 1.4 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Earnings due: Nov 4

*** please verify all earnings dates ***
1 Watcher
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical BHC trend table...

Date Alert Name Type % Chg
Bearish Engulfing Bearish 0.00%
Multiple of Ten Bearish Other 0.00%
Inside Day Range Contraction 0.00%
Overbought Stochastic Strength 0.00%
MACD Bullish Centerline Cross Bullish -1.17%
Pocket Pivot Bullish Swing Setup -1.17%
Multiple of Ten Bearish Other -1.17%
Overbought Stochastic Strength -1.17%
Multiple of Ten Bearish Other -0.07%
Outside Day Range Expansion -0.07%

Older signals for BHC ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Get Started for Free!
Configure default chart indicators
BHC Chart by TradingView
Basic chart:
Profile
Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. It also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.
S&P/Tsx 60 Index Medicine Biotechnology Laser Psoriasis Acne Actinic Keratosis
Is BHC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 1 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Oct 23 Bausch Health Licenses Clearside Biomedical's XIPERE™ (Triamcinolone Acetonide Suprachoroidal Injectable Suspension), An Investigational Treatment For Macular Edema Associated With Uveitis
Oct 21 Is Bausch Health Companies (BHC) A Good Stock To Buy?
Oct 21 Bausch + Lomb Introduces PreserVision® AREDS 2 Formula Minigel Eye Vitamins
Oct 18 How Much Of Bausch Health Companies Inc. (NYSE:BHC) Do Institutions Own?
Oct 15 Citron Calls Bausch Health — Formerly Valeant — The 'Textbook Turnaround'
Oct 15 Citron Fueling Flood of Bausch Health Call Volume
Oct 15 Bausch Health's Ortho Dermatologics Business To Present Data At The Fall Clinical Dermatology Conference
Oct 10 Ortho Dermatologics Announces 2019 Aspire Higher Scholarship Recipients
Oct 7 Bausch + Lomb Announces New Scientific And Clinical Analyses To Be Presented During The American Academy Of Ophthalmology And American Academy Of Optometry Annual Meetings
Oct 4 Bausch Health Companies Inc. Will Release Third-Quarter 2019 Financial Results on November 4
See more BHC news...
Indicators
Indicator Value
52 Week High 36.32
52 Week Low 23.6
Average Volume 771,163
200-Day Moving Average 30.9816
50-Day Moving Average 28.6684
20-Day Moving Average 27.6895
10-Day Moving Average 28.08
Average True Range 1.0425
ADX 26.86
+DI 26.771
-DI 16.515
Chandelier Exit (Long, 3 ATRs ) 27.9125
Chandelier Exit (Short, 3 ATRs ) 28.0175
Upper Bollinger Band 31.1771
Lower Bollinger Band 24.2019
Percent B (%b) 0.77
BandWidth 25.190776
MACD Line 0.1138
MACD Signal Line -0.35
MACD Histogram 0.4638
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 30.630
Resistance 3 (R3) 30.740 30.490 30.450
Resistance 2 (R2) 30.490 30.215 30.435 30.390
Resistance 1 (R1) 30.020 30.045 29.895 29.910 30.330
Pivot Point 29.770 29.770 29.708 29.715 29.770
Support 1 (S1) 29.300 29.495 29.175 29.190 28.770
Support 2 (S2) 29.050 29.325 28.995 28.710
Support 3 (S3) 28.580 29.050 28.650
Support 4 (S4) 28.470